Entries by connective

Abcam and Shuwen Biotech sign strategic MoU to establish global alliance for companion diagnostic (CDx) kit development

Cambridge, UK and Deqing, China, April 26, 2018 : Abcam, an innovator in reagents and tools, today signed a Memorandum of Understanding (MoU) with Shuwen Biotech, a leading player in the development and commercialization of companion diagnostics (CDx). Through the agreement, Abcam and Shuwen will jointly leverage their respective capabilities, in producing high-quality antibodies and […]

New CatchPoint® SimpleStep® ELISA fluorescent 90-minute assay

Cambridge, UK – 7 February 2018: CatchPoint® SimpleStep® ELISA (SSE) kits provide a simple and fast protocol with a single-wash step, assay time of 90 minutes or less, and a fluorometric readout that delivers an extended dynamic range. Developed using Abcam’s SimpleStep ELISA technology and Molecular Devices’ CatchPoint fluorescent substrate, the addition of these kits […]

Introducing FirePlex®-HT High-throughput Multiplex Immunoassays – Delivering More Data from Precious Samples

Cambridge, UK, 6 February 2018: FirePlex®-HT Immunoassays offer a no-wash workflow in 384-well plate format, enabling multiplex quantification of up to 10 protein analytes per well from as little as 6.25ul of plasma, serum, or cell culture supernatant. A 2-step protocol limits hands-on time and can be easily automated, making the assay well-suited to high-throughput […]

Abcam and Molecular Devices announce strategic collaboration

First CatchPoint® SimpleStep® ELISA kits launching at SLAS 2018, Feb 3-7, San Diego, USA Cambridge, UK, San Jose, CA, USA, February 5, 2018: Abcam, a global innovator in life science reagents and tools, and Molecular Devices, LLC, a leading provider of high-performance bioanalytical measurement solutions for the life science industry, today announced a strategic collaboration […]

Abcam wins another CiteAb award

Award recognises antibody company with sustained success in China The 2018 CiteAb awards have been announced and we are thrilled to have won antibody company with sustained success in China. One of Abcam’s core goals is to make sure that life scientists have access to the best reagents for their research. We offer a global […]

Abcam signs exclusive license agreement with Roche

The product portfolio of Spring Bioscience Corporation to be licensed to Abcam for research use only (RUO) applications The portfolio includes 243 recombinant rabbit monoclonal antibodies Cambridge, UK, 22 January 2018: Abcam plc (“Abcam”), a global leader in the supply of life science research tools, is pleased to announce that it has entered into a […]

Abcam and TTP Labtech collaborate to develop sol-R reagent kits

Assay-ready kits will incorporate fully-validated, industry-leading recombinant antibody technology for high-throughput research Cambridge, UK, 16 August 2017: TTP Labtech Ltd, a global leader in the design and development of automated instrumentation and consumables for life science applications, and Abcam plc, a global innovator in life sciences reagents and tools, today announced a collaboration to further […]

The University of Bath enters licensing agreement with Abcam to develop fluorescent detection probe kit for sugar-damaged proteins

New tool to help researchers gain new insights into age-related degenerative disease Bath, UK, 21 July 2017: The University of Bath today announced it had entered a licensing agreement with Abcam, an innovator in reagents and tools, to make a new fluorescent detection probe kit (ab219802) for researchers globally. The product developed by scientists at […]

Abcam announces first international Epigenetics conference in South Korea

Prominent Epigenetics Expert, Professor Sung Hee Baek to host event Cambridge, UK, 26 June 2017: Abcam plc, a global leader in the supply of innovative life science reagents and tools today announced its upcoming international conference “Epigenetic Regulatory Pathways”, to be held in Seoul, South Korea, from 26-28 June 2017. Korean and international experts will […]

Abcam wins two CiteAb awards

Awards are for antibody company of the year and most exciting antibody validation initiative Making sure that scientists have the best possible reagents for their research has been one of our core values since Abcam’s earliest beginnings. By providing researchers with reagents that work first time, we are helping to speed up the progress of […]